How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?

(1) Background: <i>Aspergillus</i> produces high morbidity and mortality, especially in at-risk populations. In Spain, the evolution of mortality in recent years due to this fungus is not well established. The aim of this study was to estimate the case fatality rate of aspergillosis in i...

Full description

Bibliographic Details
Main Authors: Pablo González-García, Montserrat Alonso-Sardón, Beatriz Rodríguez-Alonso, Hugo Almeida, Ángela Romero-Alegría, Víctor-José Vega-Rodríguez, Amparo López-Bernús, Juan Luis Muñoz-Bellido, Antonio Muro, Javier Pardo-Lledías, Moncef Belhassen-García
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Journal of Fungi
Subjects:
Online Access:https://www.mdpi.com/2309-608X/8/6/576
_version_ 1797485718233153536
author Pablo González-García
Montserrat Alonso-Sardón
Beatriz Rodríguez-Alonso
Hugo Almeida
Ángela Romero-Alegría
Víctor-José Vega-Rodríguez
Amparo López-Bernús
Juan Luis Muñoz-Bellido
Antonio Muro
Javier Pardo-Lledías
Moncef Belhassen-García
author_facet Pablo González-García
Montserrat Alonso-Sardón
Beatriz Rodríguez-Alonso
Hugo Almeida
Ángela Romero-Alegría
Víctor-José Vega-Rodríguez
Amparo López-Bernús
Juan Luis Muñoz-Bellido
Antonio Muro
Javier Pardo-Lledías
Moncef Belhassen-García
author_sort Pablo González-García
collection DOAJ
description (1) Background: <i>Aspergillus</i> produces high morbidity and mortality, especially in at-risk populations. In Spain, the evolution of mortality in recent years due to this fungus is not well established. The aim of this study was to estimate the case fatality rate of aspergillosis in inpatients from 1997 to 2017 in Spain. (2) Methodology: A retrospective descriptive study was conducted with records of inpatients admitted to the National Health System with a diagnosis of aspergillosis. (3) Principal findings: Of 32,960 aspergillosis inpatients, 24.5% of deaths were registered, and 71% of the patients who died were men. The percentage of deaths increased progressively with age. The case fatality rate progressively decreased over the period, from 25.4 and 27.8% in 1997–1998 to values of 20.6 and 20.8% in 2016 and 2017. Influenza and pneumonia occurrence/association significantly increased case fatality rates in all cases. (4) Conclusions: Our study shows that lethality significantly decreased in the last two decades despite the increase in cases. This highlights the fact that patients with solid and/or hematological cancer do not have a much higher mortality rate than the group of patients with pneumonia or influenza alone, these two factors being the ones that cause the highest CFRs. We also need studies that analyze the causes of mortality to decrease it and studies that evaluate the impact of COVID-19.
first_indexed 2024-03-09T23:22:53Z
format Article
id doaj.art-db7a0fc8a822439e9b6330a859d9757f
institution Directory Open Access Journal
issn 2309-608X
language English
last_indexed 2024-03-09T23:22:53Z
publishDate 2022-05-01
publisher MDPI AG
record_format Article
series Journal of Fungi
spelling doaj.art-db7a0fc8a822439e9b6330a859d9757f2023-11-23T17:24:23ZengMDPI AGJournal of Fungi2309-608X2022-05-018657610.3390/jof8060576How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?Pablo González-García0Montserrat Alonso-Sardón1Beatriz Rodríguez-Alonso2Hugo Almeida3Ángela Romero-Alegría4Víctor-José Vega-Rodríguez5Amparo López-Bernús6Juan Luis Muñoz-Bellido7Antonio Muro8Javier Pardo-Lledías9Moncef Belhassen-García10Servicio de Medicina Interna, Hospital Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, 39008 Santander, SpainÁrea de Medicina Preventiva, Epidemiología y Salud Pública, IBSAL, CIETUS, Universidad de Salamanca, 37007 Salamanca, SpainServicio de Medicina Interna, Unidad de Enfermedades Infecciosas CAUSA, IBSAL, CIETUS, 37007 Salamanca, SpainServiçio de Medicina Interna, Unidade Local de Saúde de Guarda, 6300 Guarda, PortugalServicio de Medicina Interna, Unidad de Enfermedades Infecciosas CAUSA, IBSAL, CIETUS, 37007 Salamanca, SpainServicio de Medicina Interna, CAUSA, 37007 Salamanca, SpainServicio de Medicina Interna, Unidad de Enfermedades Infecciosas CAUSA, IBSAL, CIETUS, 37007 Salamanca, SpainServicio de Microbiología y Parasitología, CAUSA, CIETUS, IBSAL, Departamento de Ciencias Biomédicas y del Diagnóstico, Universidad de Salamanca, CSIC, 37007 Salamanca, SpainInfectious and Tropical Diseases Group (e-INTRO), IBSAL-CIETUS, Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, SpainServicio de Medicina Interna, Hospital Marqués de Valdecilla, IDIVAL, Universidad de Cantabria, 39008 Santander, SpainServicio de Medicina Interna, Unidad de Enfermedades Infecciosas CAUSA, IBSAL, CIETUS, 37007 Salamanca, Spain(1) Background: <i>Aspergillus</i> produces high morbidity and mortality, especially in at-risk populations. In Spain, the evolution of mortality in recent years due to this fungus is not well established. The aim of this study was to estimate the case fatality rate of aspergillosis in inpatients from 1997 to 2017 in Spain. (2) Methodology: A retrospective descriptive study was conducted with records of inpatients admitted to the National Health System with a diagnosis of aspergillosis. (3) Principal findings: Of 32,960 aspergillosis inpatients, 24.5% of deaths were registered, and 71% of the patients who died were men. The percentage of deaths increased progressively with age. The case fatality rate progressively decreased over the period, from 25.4 and 27.8% in 1997–1998 to values of 20.6 and 20.8% in 2016 and 2017. Influenza and pneumonia occurrence/association significantly increased case fatality rates in all cases. (4) Conclusions: Our study shows that lethality significantly decreased in the last two decades despite the increase in cases. This highlights the fact that patients with solid and/or hematological cancer do not have a much higher mortality rate than the group of patients with pneumonia or influenza alone, these two factors being the ones that cause the highest CFRs. We also need studies that analyze the causes of mortality to decrease it and studies that evaluate the impact of COVID-19.https://www.mdpi.com/2309-608X/8/6/576aspergillosishuman aspergillosisinvasive fungal diseasescase fatality rateSpain
spellingShingle Pablo González-García
Montserrat Alonso-Sardón
Beatriz Rodríguez-Alonso
Hugo Almeida
Ángela Romero-Alegría
Víctor-José Vega-Rodríguez
Amparo López-Bernús
Juan Luis Muñoz-Bellido
Antonio Muro
Javier Pardo-Lledías
Moncef Belhassen-García
How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
Journal of Fungi
aspergillosis
human aspergillosis
invasive fungal diseases
case fatality rate
Spain
title How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
title_full How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
title_fullStr How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
title_full_unstemmed How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
title_short How Has the Aspergillosis Case Fatality Rate Changed over the Last Two Decades in Spain?
title_sort how has the aspergillosis case fatality rate changed over the last two decades in spain
topic aspergillosis
human aspergillosis
invasive fungal diseases
case fatality rate
Spain
url https://www.mdpi.com/2309-608X/8/6/576
work_keys_str_mv AT pablogonzalezgarcia howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT montserratalonsosardon howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT beatrizrodriguezalonso howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT hugoalmeida howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT angelaromeroalegria howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT victorjosevegarodriguez howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT amparolopezbernus howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT juanluismunozbellido howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT antoniomuro howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT javierpardolledias howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain
AT moncefbelhassengarcia howhastheaspergillosiscasefatalityratechangedoverthelasttwodecadesinspain